Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sonnet Biotherapeutics Holdings Inc SONN

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the FHAB construct to improve drug accumulation in tumors, and to extend the duration of activity in the body. Its lead asset, SON-1010, is a fully human single-chain version of Interleukin 12, covalently linked to the FHAB construct, for which it is pursuing clinical development in solid tumors. Its lead clinical stage asset, SON-080, is the native human version of IL-6 that is manufactured in Chinese Hamster Ovary cells. SON-080, for its target indications of Chemotherapy-Induced Peripheral Neuropathy and Diabetic Peripheral Neuropathy. Its pipeline also includes SON-1210, SON-1410 and SON-3015.


NDAQ:SONN - Post by User

Post by MissionIRon Feb 03, 2014 7:03pm
268 Views
Post# 22167792

Chanticleer Holdings, Inc. (HOTR) Expands Portfolio, Acquire

Chanticleer Holdings, Inc. (HOTR) Expands Portfolio, Acquire

Chanticleer Holdings, Inc. (HOTR) Expands Portfolio, Acquires Hooters Pacific Northwest Franchise

Chanticleer Holdings, a minority holder in the privately held parent company of the Hooters® brand Hooters Of America and a franchisee of international Hooters restaurants, has completed its acquisition of Hooters U.S. Pacific Northwest franchise rights and two existing restaurants in Oregon and Washington.

Chanticleer has acquired 100 percent of the shares of Tacoma Wings, LLC and Hooters of Oregon Partners, LLC, owners and operators of the two locations in Portland, Ore., and Tacoma, Wash. Per the agreement, Chanticleer has obtained all leasehold and current franchise rights to the Hooters locations in Oregon and Washington. As part of its ongoing effort to expand its portfolio, Chanticleer management is also evaluating locations around the Portland and Seattle areas for future restaurant openings.

In addition, Chanticleer reports that it has acquired Chef John Tesar’s fine dining seafood restaurant, Spoon Bar & Kitchen, located in Dallas, Texas. Chanticleer intends to expand the Spoon brand by stretching its healthier seafood menu into a new, fast-casual dining concept.

“We are starting off the new year successfully completing both of these acquisitions and more importantly adding three operating restaurants to our portfolio. The Pacific Northwest provides strategic opportunities to expand the footprint of our brands,” Chanticleer chairman and CEO Mike Pruitt stated in the news release.

Chanticleer also owns and operates American Roadside Burgers and owns a majority interest in Just Fresh restaurants in the United States.

For more information, visit www.chanticleerholdings.com

Please read full disclaimers at https://disclaimer.missionir.com

Bullboard Posts